Ajay Kakkar, Baron Kakkar
He was educated at Alleyn's School, King's College London (BSc, 1985; MBBS, 1988) and Imperial College London (PhD, 1998). He has research interests in the prevention and treatment of venous thromboembolic disease and cancer-associated thrombosis and, in particular, the role of antithrombotic therapy in prolonging survival in cancer and the role of coagulation serine proteases in tumour biology.
Kakkar is Chair of the Clinical Quality Directorate of University College London Partners Academic Health Science Partnership, Director of the Thrombosis Research Institute, London, and lectures and publishes widely on his specialism. He has worked with the NHS on its strategy to prevent venous thromboembolism (VTE).
Among the awards Kakkar has received are Hunterian Professor, Royal College of Surgeons of England 1996, the David Patey Prize, Surgical Research Society of Great Britain and Ireland 1996, the Knoll William Harvey Prize, International Society on Thrombosis and Haemostasis 1997 and the James IV Association of Surgeons Fellow 2006. He is a Commissioner of the Royal Hospital Chelsea, Chair of the Board of Governors at Alleyn's School, Dulwich, and a Trustee of the Dulwich Estate.
He is a member of the Athenaeum Club.
Kakkar has been noted for his work promoting British business as an ambassador for the United Kingdom. He has taken 11 trips in 2014 to promote business relations.
- Thrombosis Research Institute[dead link]
- The London Gazette: . 25 March 2010.
- Department of the Official Report (Hansard), House of Lords, Westminster (2010-03-22). "Lords Hansard text for 22 March 2010". Publications.parliament.uk. Retrieved 2014-03-25.
- "Revealed: the business men selling the UK to the world". The Telegraph. Retrieved 2014-10-31.
|This biography of a life peer is a stub. You can help Wikipedia by expanding it.|
|This United Kingdom biographical article related to medicine is a stub. You can help Wikipedia by expanding it.|